Camurus

ISIN SE0007692850

 | 

WKN A2ABG7

Market cap (in EUR)
3,555 m
Country
Sweden
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals Sweden

Financials

Key metrics

Market capitalisation, EUR 3,555 m
EPS, EUR 1.18
P/B ratio 9.2
P/E ratio 48.3
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 163 m
Net income, EUR 37 m
Profit margin 22.94%

What ETF is Camurus in?

There are 3 ETFs which contain Camurus. All of these ETFs are listed in the table below. The ETF with the largest weighting of Camurus is the iShares STOXX Europe 600 Health Care UCITS ETF (DE).
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.02%
Equity
Europe
Social/Environmental
33
iShares STOXX Europe 600 Health Care UCITS ETF (DE) 0.14%
Equity
Europe
Health Care
760
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
497
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.